# Eribulin Mesylate

NDC: 0781-3391
Generic name: eribulin mesylate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250707

FDA application: ANDA214310

## Active ingredients

- ERIBULIN MESYLATE: .5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-3391"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-3391
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d122f0a4-aff7-49f7-8cf1-06bc2883ad43